Fathom Therapeutics Secures $47 Million in Series A Financing Led by Sutter Hill Ventures
Fathom Therapeutics, formerly Atommap Corp., has raised $47 million in an oversubscribed Series A round led by Sutter Hill Ventures. The funding will support the company's AI and physics-based drug design platform, Microcosmos, which aims to accelerate the discovery of next-generation medicines. The company also announced leadership changes and the establishment of a Scientific Advisory Board.
Topics: AI in healthcare board appointment drug discovery funding leadership change scientific advisory board